Patients should note the frequency, duration, pattern (regular versus irregular), associated activities or triggers, and any accompanying symptoms
Emerging research indicates that GLP-1 receptor agonistsmedications traditionally used for weight loss and blood sugar regulationmay influence brain regions associated with attention, motivation, and executive function
It acts as a dual agonist
Feb 2, 2026 Tired of sifting through conflicting information about psoriasis management
The Creator Economy Editorial oversight by the Editor-in-Chief Kourtney Kardashian Barker''s wellness and supplement brand Lemme has been named in a class-action lawsuit filed in California court over the marketing of its Lemme GLP-1 Daily capsule
Sublingual Semaglutide is a groundbreaking new treatment option for patients suffering from type-2 diabetes, and, under certain conditions, for weight management in patients with or without diabetes